MRAM vs RARE · P/E 2441, rev $33.6M vs rev $350.0M
Everspin Technologies Inc (MRAM) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Everspin Technologies Inc (MRAM) is a semiconductors company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported MRAM revenue for 2026-06-30 was $33.6M. Net income was -$3.9M. MRAM currently screens at market cap $572.4M and trailing P/E 2441.0.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
MRAM currently screens at market cap $572.4M and trailing P/E 2441.0. RARE currently screens at market cap $2.79B.
Not investment advice. Open the MRAM and RARE stock pages for the full models.
Not investment advice.